The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
RETRACTED ARTICLE: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon
Open accessPublished version of a preprint
Abstract
Background: Tumor recurrence and metastasis occur at a high rate in patients with colon cancer. Identification of effective strategies for the treatment of colon cancer is critical. Recently, poly (lactic-co-glycolic acid) (PLGA) has been shown to have potential as a broad therapeutic drug delivery system. We designed a dual-loaded nanoparticle drug delivery system to overcome the limitations of chemotherapeutic drugs used to treat colon cancer. Methods: We developed epidermal growth factor (EGF) functionalized PLGA nanoparticles (NPs) co-loaded with 5-fluorouracil (5Fu) and perfluorocarbon (PFC) (EGF-PLGA@5Fu/PFC) for targeted treatment of colon cancer. CCK-8 assay, Hoechst33342 staining and flow cytometry were performed to investigate the functions of EGF-PLGA@5Fu/PFC NPs in SW620 cells. Beside, animal experiment, histological analysis and immunofluorescence staining were adopted to further confirm the role of EGF-PLGA@5Fu/PFC NPs in vivo . Results: The findings showed that EGF-PLGA@5Fu /PFC NPs had an average size 200 nm and a 5Fu-loading efficiency of 7.29%. Furthermore, in vitro release was pH-sensitive. Targeted EGF-PLGA@5Fu/PFC NPs exhibited higher cellular uptake than non-targeted NPs into colon cancer cells. In addition, EGF-PLGA@5Fu/PFC NPs suppressed cell viability and induced apoptosis in SW620 cells to a greater extent than non-targeted NPs. In tumor xenografted mice, EGF-PLGA@5Fu/PFC NPs suppressed tumor growth more effectively than 5Fu, PLGA@5Fu or PLGA@5Fu/PFC NPs. Histopathological analysis further demonstrated that EGF-targeted NPs inhibited tumor growth to a greater extent than non-targeted or non-NP treatments. The improved therapeutic outcomes observed in this study were due to relief of tumor hypoxia by transport of oxygen by PFC to the tumors. Conclusion: We constructed a biocompatible nanodrug delivery system based on functionalized nanoparticles that provided a novel strategy for selective delivery of chemotherapy drugs to tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, EGF-targeted 5-FU-loaded PLGA NPs were developed to selectively target CRC cells expressing high levels of EGFR and showed higher rates of cytotoxicity and apoptosis and lower rates of tumor growth compared to non-targeted or non-NP treatments [115].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Xie, X., Tao, Q., Zou, Y., Zhang, F., Guo, M., Wang, Y., Wang, H., Zhou, Q., & Yu, S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202135j · Cited by 393
Self-citationNanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine‐19 MRI
Ahrens, E. T., Helfer, B. M., O'Hanlon, C. F., & Schirda, C. (2014) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25454 · Cited by 242
A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes
Handali, S., Moghimipour, E., Rezaei, M., Ramezani, Z., Kouchak, M., Amini, M., Angali, K. A., Saremy, S., & Dorkoosh, F. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.128 · Cited by 154
Cited by
Alsaab, H. O., Alharbi, F. D., Alhibs, A. S., Alanazi, N. B., Alshehri, B. Y., Saleh, M. A., Alshehri, F. S., Algarni, M. A., Almugaiteeb, T., Uddin, M. N., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122728 · Cited by 289
“but also greatly minimize side effects [72].”
BackgroundNarmani, A., Jahedi, R., Bakhshian-Dehkordi, E., Ganji, S., Nemati, M., Ghahramani‐Asl, R., Moloudi, K., Hosseini, S. M., Bagheri, H., Kesharwani, P., et al. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2223941 · Cited by 111
“EPR effect is also crucial for transporting fundamental biomaterials into rapidly growing solid tumors [107].”
BackgroundNanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology
Hristova‐Panusheva, K., Xenodochidis, C., Georgieva, M., & Krasteva, N. A. (2024) · Pharmaceuticals · doi:10.3390/ph17060677 · Cited by 131
“Other examples are the EGF-functionalized PLGA NPs loaded with 5-FU and perfluorocarbons, which have been shown to inhibit colon tumour growth [110].”
BackgroundWeibull β value for the discernment of drug release mechanism of PLGA particles
Martín-Camacho, U. D. J., Rodríguez-Barajas, N., Sánchez-Burgos, J. A., & Larios, A. P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123017 · Cited by 131
Mesenchymal stem cell-based nanoparticles and scaffolds in regenerative medicine
Raghav, P. K., Mann, Z., Ahlawat, S., & Mohanty, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174657 · Cited by 97
Metadata
- Authors
- Wu, P., Zhou, Q., Zhu, H., Zhuang, Y., & Bao, J.
- Affiliations
- Jiangsu Cancer Hospital (CN)
- Corresponding author
- Bao, Jun
- Venue
- BMC Cancer
- Published
- 2020-04-28
- Volume
- 20
- Issue
- 1
- Pages
- 354-354
- ISSN
- 1471-2407 (ISSN-L)
- PMC
- PMC7189558
- OpenAlex
- W3018948488
- Cited by
- 97
- References
- 32
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 19 · 2021: 11 · 2020: 1
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2026-08-22)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Cancer (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Youth Foundation of China (No. 81601604)
- Innovative Research Group Project of the National Natural Science Foundation of China (No. BK20161070)
- the talents program of Jiangsu Cancer Hospital (No. YC201809)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- colon cancer, PLGA nanoparticles, 5-fluorouracil, perfluorocarbons, tumor hypoxia, oxygen delivery, targeted drug delivery, chemotherapy, apoptosis, tumor xenografts, retracted article
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Antimetabolites, Antineoplastic, Colonic Neoplasms, Drug Carriers, Drug Therapy, Combination, Epidermal Growth Factor, Female, Fluorocarbons, Fluorouracil, Humans, Mice, Inbred BALB C, Mice, Nude, Tumor Cells, Cultured, Drug Delivery Systems, Apoptosis, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, Nanoparticles, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RETRACTED ARTICLE: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. https://app.cochat.ai/papers/10.1186/s12885-020-06803-7
- The paper
- Wu, P., Zhou, Q., Zhu, H., Zhuang, Y., & Bao, J. (2020). RETRACTED ARTICLE: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. BMC Cancer. https://doi.org/10.1186/s12885-020-06803-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.